CY1106820T1 - Ανοσοδοκιμασιες για αντι-hcv αντισωματα - Google Patents

Ανοσοδοκιμασιες για αντι-hcv αντισωματα

Info

Publication number
CY1106820T1
CY1106820T1 CY20071101092T CY071101092T CY1106820T1 CY 1106820 T1 CY1106820 T1 CY 1106820T1 CY 20071101092 T CY20071101092 T CY 20071101092T CY 071101092 T CY071101092 T CY 071101092T CY 1106820 T1 CY1106820 T1 CY 1106820T1
Authority
CY
Cyprus
Prior art keywords
immunoassay
hcv antibodies
immunoassays
hcv
epitope
Prior art date
Application number
CY20071101092T
Other languages
English (en)
Inventor
David Y. Chien
Phillip Arcangel
Laura Tandeske
Carlos George-Nasciemento
Doris Coit
Angelica Medina-Selby
Original Assignee
Novartis Vaccines And Diagnostics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27395684&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1106820(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Vaccines And Diagnostics, Inc. filed Critical Novartis Vaccines And Diagnostics, Inc.
Publication of CY1106820T1 publication Critical patent/CY1106820T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/18—Togaviridae; Flaviviridae
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/10—Detection of antigens from microorganism in sample from host
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms

Abstract

Παρέχονται ΗCV ανοσοδοκιμασίες που περιλαμβάνουν ΝS3/4a διαμορφωτικό επίτοπο και ένα αντιγόνο σύντηξης πολλαπλού επίτοπου, καθώς επίσης στερεά υποστρώματα ανοσοδοκιμασίας για χρήση με τις ανοσοδοκιμασίες.
CY20071101092T 2000-06-15 2007-08-20 Ανοσοδοκιμασιες για αντι-hcv αντισωματα CY1106820T1 (el)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US21208200P 2000-06-15 2000-06-15
US28086701P 2001-04-02 2001-04-02
US28081101P 2001-04-02 2001-04-02
PCT/US2001/019156 WO2001096870A2 (en) 2000-06-15 2001-06-14 Immunoassays for anti-hcv antibodies

Publications (1)

Publication Number Publication Date
CY1106820T1 true CY1106820T1 (el) 2012-05-23

Family

ID=27395684

Family Applications (2)

Application Number Title Priority Date Filing Date
CY20071100319T CY1107537T1 (el) 2000-06-15 2007-03-07 Ανaλυση συνδυασμoy hcv αντιγoνου/αντισωματος
CY20071101092T CY1106820T1 (el) 2000-06-15 2007-08-20 Ανοσοδοκιμασιες για αντι-hcv αντισωματα

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CY20071100319T CY1107537T1 (el) 2000-06-15 2007-03-07 Ανaλυση συνδυασμoy hcv αντιγoνου/αντισωματος

Country Status (23)

Country Link
US (5) US6630298B2 (el)
EP (2) EP1350105B1 (el)
JP (3) JP4837229B2 (el)
CN (3) CN1214244C (el)
AT (2) ATE348337T1 (el)
AU (2) AU2001272945A1 (el)
BG (1) BG66205B1 (el)
BR (2) BRPI0111731C1 (el)
CA (2) CA2413003C (el)
CY (2) CY1107537T1 (el)
CZ (1) CZ304185B6 (el)
DE (2) DE60125240T3 (el)
DK (2) DK1354204T4 (el)
ES (2) ES2288969T3 (el)
HK (2) HK1061861A1 (el)
HU (1) HU228873B1 (el)
MX (2) MXPA02012424A (el)
NO (1) NO332275B1 (el)
PL (1) PL213363B1 (el)
PT (2) PT1350105E (el)
SI (1) SI1354204T2 (el)
SK (1) SK287694B6 (el)
WO (2) WO2001096875A2 (el)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1421951A3 (en) * 1993-05-12 2005-10-05 Chiron Corporation Conserved motif of hepatitis C virus E2/NS1 region
US7491808B2 (en) * 2000-06-15 2009-02-17 Novartis Vaccines And Diagnostics, Inc. HCV non-structural protein mutants and uses thereof
SK287694B6 (sk) * 2000-06-15 2011-06-06 Novartis Vaccines & Diagnostics, Inc. Pevný nosič imunoeseje a spôsob jeho prípravy, spôsob detekcie infekcie HIV a súprava na imunodiagnostickú skúšku
AU2001292151B2 (en) * 2000-08-17 2006-05-04 Tripep Ab Vaccines containing ribavirin and methods of use thereof
US7022830B2 (en) 2000-08-17 2006-04-04 Tripep Ab Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
DE10106295C1 (de) * 2001-02-02 2002-08-22 Gaifar German American Inst Fo Protein mit mehreren Antigen-Epitop-Sequenzen, welches immobilisiert ist
SG118120A1 (en) * 2001-03-28 2006-01-27 Ortho Clinical Diagnostics Inc A hepatitis C antigen - antibody combination assayfor the early detection of HCV infection
WO2003002749A2 (en) 2001-06-26 2003-01-09 Abbott Laboratories Methods for the simultaneous detection of hcv antigens and hcv antibodies
US7101683B2 (en) * 2001-06-26 2006-09-05 Abbott Laboratories Methods for the simultaneous detection of HCV antigens and HCV antibodies
US7049060B2 (en) * 2001-11-05 2006-05-23 Ortho-Clinical Diagnostics, Inc. HCV anti-core monoclonal antibodies
US7332269B2 (en) * 2001-11-11 2008-02-19 Ortho-Clinical Diagnostics, Inc. HCV core protein sequences
FR2839555B1 (fr) * 2002-05-10 2007-07-27 Bio Rad Pasteur Procede de detection simultanee d'un antigene et d'un anticorps d'un microorganisme infectieux
CN1694971B (zh) * 2002-09-09 2010-05-26 诺华疫苗和诊断公司 Hcv检测
US20040152070A1 (en) * 2003-02-04 2004-08-05 Shah Dinesh O. Method of detection of HCV antibodies in combination assay or sole antibody assay
EP1668369B1 (en) 2003-08-20 2016-01-06 ProMIS Neurosciences Inc. Epitope protection assay and method for detecting protein conformations
WO2006033768A2 (en) * 2004-08-27 2006-03-30 Novartis Vaccines And Diagnostics Inc. Hcv multiple epitope fusion antigens with modified proteolytic cleavage sites and uses thereof
JP2008529015A (ja) * 2005-02-02 2008-07-31 鵬 崔 Ｈｃｖ抗体を検出するためのキットおよびその調製方法
EP2360175B1 (en) 2005-11-22 2014-07-16 Novartis Vaccines and Diagnostics, Inc. Norovirus and Sapovirus virus-like particles (VLPs)
US7887803B2 (en) 2005-12-02 2011-02-15 Amorfix Life Sciences Methods and compositions to treat misfolded-SOD1 mediated diseases
US7794692B2 (en) * 2005-12-02 2010-09-14 Amorfix Life Sciences Ltd. Methods and compositions for detecting amyotrophic lateral sclerosis
EP2495327B1 (en) 2006-03-03 2016-09-28 ProMIS Neurosciences Inc. Methods and compositions to treat and detect misfolded-SOD1 mediated diseases
CN1908666B (zh) * 2006-08-14 2010-05-12 武汉大学 一种检测乙肝核心抗体的双夹心法酶联免疫诊断试剂盒及应用
US8071561B2 (en) 2007-08-16 2011-12-06 Chrontech Pharma Ab Immunogen platform
BRPI1009801A2 (pt) * 2009-03-30 2016-03-15 Biomerieux Sa suporte sólido para detecção do hcv
US20100297607A1 (en) * 2009-05-20 2010-11-25 Jian Zheng Reagents For HCV Antigen-Antibody Combination Assays
US9744228B2 (en) 2010-04-07 2017-08-29 Norvartis Ag Method for generating a parvovirus B19 virus-like particle
CN106771219B (zh) * 2010-06-17 2020-04-07 皇家飞利浦电子股份有限公司 多表位测定
CN103154242B (zh) 2010-07-06 2015-09-30 诺华股份有限公司 诺如病毒衍生的免疫原性组合物和方法
WO2012006500A2 (en) * 2010-07-08 2012-01-12 Abbott Laboratories Monoclonal antibodies against hepatitis c virus core protein
WO2012097304A2 (en) * 2011-01-13 2012-07-19 Ortho-Clinical Diagnostics, Inc. Treponema pallidum triplet antigen
FR2984328B1 (fr) 2011-12-20 2016-12-30 Bio-Rad Innovations Procede de detection d'une infection par le virus de l'hepatite c
CN105378099B (zh) 2013-03-14 2021-05-11 雅培制药有限公司 Hcv核心脂质结合结构域单克隆抗体
MX362075B (es) 2013-03-14 2019-01-07 Abbott Lab Ensayo de combinación de antígeno-anticuerpo del virus de la hepatitis c (vhc) y métodos y composiciones para usarlo.
US9790478B2 (en) 2013-03-14 2017-10-17 Abbott Laboratories HCV NS3 recombinant antigens and mutants thereof for improved antibody detection
CN103630690B (zh) * 2013-12-17 2014-08-20 朱之炜 丙型肝炎病毒抗原抗体联合检测试剂盒及其检测方法
CA2980718C (en) 2015-03-27 2021-06-01 Ortho-Clinical Diagnostics, Inc. Hcv ns4a/modified ns3 polypeptides and uses thereof
EP3285806A4 (en) * 2015-04-20 2019-03-27 Qoolabs, Inc. SINGLE DOMAIN CAMELID HCV ANTIBODIES AND METHODS OF USE THEREOF
WO2019067415A1 (en) * 2017-09-27 2019-04-04 Bio-Rad Laboratories, Inc. DIGITAL AFFINITY LINK ASSAY
CN110261616B (zh) * 2019-04-30 2021-07-20 广东菲鹏生物有限公司 一种丙型肝炎病毒检测试剂盒
CN115838420B (zh) * 2022-10-31 2023-05-05 北京科跃中楷生物技术有限公司 一种可溶性hcv重组蛋白的制备方法及其制备的抗体检测试剂

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2212511B (en) * 1987-11-18 1992-01-22 Chiron Corp Hepatitis c virus
US5683864A (en) * 1987-11-18 1997-11-04 Chiron Corporation Combinations of hepatitis C virus (HCV) antigens for use in immunoassays for anti-HCV antibodies
US6171782B1 (en) 1987-11-18 2001-01-09 Chiron Corporation Antibody compositions to HCV and uses thereof
ES2012739T5 (es) 1987-11-18 2001-12-01 Chiron Corp Diagnosticos para nanbv.
US5350671A (en) 1987-11-18 1994-09-27 Chiron Corporation HCV immunoassays employing C domain antigens
JP2730153B2 (ja) 1989-03-16 1998-03-25 日本合成ゴム株式会社 熱可塑性樹脂組成物およびその製造方法
HUT54896A (en) * 1989-03-17 1991-04-29 Chiron Corp Process for producing aquous diagnosticum and vaccine of nanbv
ES2166749T3 (es) * 1989-05-18 2002-05-01 Chiron Corp Diagnosticos de nanbv: polinucleotidos utiles para discriminar virus de la hepatitis c.
RO109916B1 (ro) * 1990-04-04 1995-07-28 Chiron Corp Compozitie de antigeni ai hepatitei virale c
US6194140B1 (en) * 1990-04-04 2001-02-27 Chiron Corporation HCV NS3 protein fragments having helicase activity and improved solubility
US5712087A (en) 1990-04-04 1998-01-27 Chiron Corporation Immunoassays for anti-HCV antibodies employing combinations of hepatitis C virus (HCV) antigens
CA2049679C (en) 1990-08-24 2005-06-21 Sushil G. Devare Hepatitis c assay utilizing recombinant antigens
PT97247B (pt) * 1991-04-03 1997-10-31 Chiron Corp Processo de preparacao de combinacoes de antigenios do virus da hepapite c (hcv) para uso em imunoensaios para anticorpos anti-hcv
RU2148587C1 (ru) 1991-06-24 2000-05-10 Чирон Корпорейшн Полипептид и способ его получения, реагент для иммуноанализа, способ определения присутствия антител и способ индукции иммунного ответа
UA39944C2 (uk) 1992-07-07 2001-07-16 Чірон Корпорейшн Спосіб визначення ранньої сероконверсії у ссавця-хазяїна до вірусу гепатиту с і набір для використання в способі
ATE552340T1 (de) * 1993-04-27 2012-04-15 Innogenetics Nv Hepatitis c virus genotypsequenzen sowie ihre verwendung als behandlungs- und nachweismitteln
US6001604A (en) * 1993-12-29 1999-12-14 Bio-Technology General Corp. Refolding of proinsulins without addition of reducing agents
JP3217600B2 (ja) 1994-07-12 2001-10-09 株式会社先端生命科学研究所 非ａ非ｂ型肝炎ウイルス関連抗原のイムノアッセイ、それに使用するモノクローナル抗体、およびこの抗体を産生するハイブリドーマ
DE4428705A1 (de) * 1994-08-12 1996-02-15 Boehringer Mannheim Gmbh Rekombinantes Antigen aus der NS3-Region des Hepatitis C Virus
US5843752A (en) 1995-05-12 1998-12-01 Schering Corporation Soluble active hepatitis C virus protease
US5990276A (en) 1996-05-10 1999-11-23 Schering Corporation Synthetic inhibitors of hepatitis C virus NS3 protease
US6514731B1 (en) * 1996-05-24 2003-02-04 Chiron Corporation Methods for the preparation of hepatitis C virus multiple copy epitope fusion antigens
DE69734776T2 (de) * 1996-05-24 2006-08-17 Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville Fusionsprotein mit multiplen Epitopen
US6322965B1 (en) * 1997-02-10 2001-11-27 Advanced Life Science Institute, Inc. Chimera antigen peptide
US6391540B1 (en) * 1997-09-22 2002-05-21 Chiron Corporation Method for detecting antibodies in a sample
JP3514729B2 (ja) * 1998-07-30 2004-03-31 株式会社先端生命科学研究所 Ｃ型肝炎ウイルスの測定方法
SK287694B6 (sk) * 2000-06-15 2011-06-06 Novartis Vaccines & Diagnostics, Inc. Pevný nosič imunoeseje a spôsob jeho prípravy, spôsob detekcie infekcie HIV a súprava na imunodiagnostickú skúšku

Also Published As

Publication number Publication date
WO2001096870A2 (en) 2001-12-20
DK1354204T4 (da) 2010-06-14
US6632601B2 (en) 2003-10-14
HUP0500444A2 (hu) 2005-08-29
US6630298B2 (en) 2003-10-07
DE60125240T2 (de) 2007-07-12
NO20025878D0 (no) 2002-12-06
DK1354204T3 (da) 2007-04-10
US6797809B2 (en) 2004-09-28
ES2277932T5 (es) 2010-06-28
HU228873B1 (hu) 2013-06-28
HK1061861A1 (en) 2004-10-08
PT1350105E (pt) 2007-08-13
WO2001096875A9 (en) 2002-08-15
AU2001272945A1 (en) 2001-12-24
US20040063092A1 (en) 2004-04-01
EP1350105A2 (en) 2003-10-08
CN1256591C (zh) 2006-05-17
EP1354204B1 (en) 2006-12-13
SK287694B6 (sk) 2011-06-06
CN1466682A (zh) 2004-01-07
BR0111731A (pt) 2004-02-10
NO20025878L (no) 2003-02-12
SK17772002A3 (sk) 2003-10-07
CA2413003C (en) 2013-08-13
CA2412035C (en) 2012-04-10
CA2413003A1 (en) 2001-12-20
JP4837229B2 (ja) 2011-12-14
ATE348337T1 (de) 2007-01-15
US20020146685A1 (en) 2002-10-10
CN1214244C (zh) 2005-08-10
US7241879B2 (en) 2007-07-10
CY1107537T1 (el) 2013-03-13
PL365599A1 (en) 2005-01-10
DK1350105T3 (da) 2007-11-12
BRPI0111731C1 (pt) 2021-07-27
DE60129598D1 (de) 2007-09-06
BRPI0111731B1 (pt) 2016-07-05
ATE368221T1 (de) 2007-08-15
JP2011125350A (ja) 2011-06-30
US7319144B2 (en) 2008-01-15
PL213363B1 (pl) 2013-02-28
WO2001096875A3 (en) 2003-08-28
BRPI0111682B8 (pt) 2021-07-27
CZ304185B6 (cs) 2013-12-11
BG66205B1 (bg) 2012-01-31
HK1079796A1 (en) 2006-04-13
WO2001096875A2 (en) 2001-12-20
DE60125240T3 (de) 2010-10-28
US20040265801A1 (en) 2004-12-30
JP4834279B2 (ja) 2011-12-14
EP1354204A2 (en) 2003-10-22
CN100463922C (zh) 2009-02-25
CZ20024058A3 (cs) 2003-09-17
EP1354204B2 (en) 2010-04-21
DE60125240D1 (de) 2007-01-25
NO332275B1 (no) 2012-08-13
US20020192639A1 (en) 2002-12-19
HUP0500444A3 (en) 2010-03-29
MXPA02012401A (es) 2003-04-25
CN1489692A (zh) 2004-04-14
WO2001096870A3 (en) 2003-07-31
JP2004506878A (ja) 2004-03-04
AU2001272948A1 (en) 2001-12-24
PT1354204E (pt) 2007-03-30
EP1350105B1 (en) 2007-07-25
BG107441A (bg) 2004-01-30
BRPI0111682B1 (pt) 2017-09-19
SI1354204T1 (sl) 2007-04-30
BRPI0111731B8 (pt) 2016-08-23
US20040096822A1 (en) 2004-05-20
MXPA02012424A (es) 2003-04-25
BR0111682A (pt) 2004-01-06
ES2277932T3 (es) 2007-08-01
SI1354204T2 (sl) 2010-09-30
ES2288969T3 (es) 2008-02-01
DE60129598T2 (de) 2008-04-17
JP2004510133A (ja) 2004-04-02
CN1660913A (zh) 2005-08-31
CA2412035A1 (en) 2001-12-20

Similar Documents

Publication Publication Date Title
CY1106820T1 (el) Ανοσοδοκιμασιες για αντι-hcv αντισωματα
CY2019029I2 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοi και χρησεις
NO20004413D0 (no) HIV peptider, antigener, vaksine, blandinger, immunoassay, kit og en fremgangmÕte for pÕvisning av antistoffer som blir infusert av HIV
CY2018010I1 (el) Anti-il-12 αντισωματα, συνθεσεις, μεθοδοι και χρησεις
CY1119291T1 (el) Πολυσθενη αντισωματα και χρησεις για αυτα
HK1105005A1 (en) Anti-influenza type a virus monoclonal antibody and immunoassay instrument using the antibody
NO20051715L (no) HCV assay
HK1096975A1 (en) Monoclonal antibody against influenza b virus and immunoassay instrument using the antibody
DK1478667T3 (da) Monoklonalt anti-humant tenascin-antistof
DE50013265D1 (de) Verpackung mit Aufreissverschluss
NO20004412D0 (no) HIV regulatoriske og hjelpepeptider, antigener, vaksine, blandinger, immunoassay, kit og en fremgangsmÕte for pÕvisning av antistoffer som blir infusert av HIV
DE60205889D1 (de) Verpackungsbeutel mit aufreissverschluss
ATE457318T1 (de) Gegen das menschliche bst2 antigen gerichteter monoklonaler antikörper
WO2006020263A3 (en) Cytoxan antibodies and immunoassay
ID28905A (id) Antibodi-antibodi dengan afinitas tinggi
ATE269350T1 (de) Solvate von erythromycin a oxim
EP1829891A3 (en) Immunoassays for Anti-HCV Antibodies
FI20011055A (fi) Heveiiniä sitovat monoklonaaliset vasta-aineet
DK1503799T3 (da) Immunogent, monoklonalt antistof
ES1046857Y (es) Aposito envasado al vacio con antiseptico.
ITRM20000041V0 (it) Borsa con doppia funzionalita'.
TR199902750A3 (tr) Anti-p53 monoklonal antikorlar ve kullanimlari.